Press Releases

Presentations

CHDI 2020: Targeting DNA Damage Response genes with oligonucleotides for therapeutic modulation of HTT somatic instability

In the News

Media contact

Eric Sullivan
Triplet Therapeutics
esullivan@triplettx.com